Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.
Zeuzem S, Soriano V, Asselah T, Gane EJ, Bronowicki JP, Angus P, Lohse AW, Stickel F, Müllhaupt B, Roberts S, Schuchmann M, Manns M, Bourlière M, Buti M, Stern JO, Gallivan JP, Voss F, Sabo JP, Böcher W, Mensa FJ; SOUND-C2 Study Group. Zeuzem S, et al. Among authors: asselah t. Antimicrob Agents Chemother. 2015 Feb;59(2):1282-91. doi: 10.1128/AAC.04383-14. Epub 2014 Dec 15. Antimicrob Agents Chemother. 2015. PMID: 25512403 Free PMC article. Clinical Trial.
Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy.
Neuman MG, Benhamou JP, Bourliere M, Ibrahim A, Malkiewicz I, Asselah T, Martinot-Peignoux M, Shear NH, Katz GG, Akremi R, Benali S, Boyer N, Lecomte L, Le Breton V, Le Guludec G, Marcellin P. Neuman MG, et al. Among authors: asselah t. Cytokine. 2002 Jan 21;17(2):108-17. doi: 10.1006/cyto.2001.0997. Cytokine. 2002. PMID: 11886178 Clinical Trial.
Fibrosis and disease progression in hepatitis C.
Marcellin P, Asselah T, Boyer N. Marcellin P, et al. Among authors: asselah t. Hepatology. 2002 Nov;36(5 Suppl 1):S47-56. doi: 10.1053/jhep.2002.36993. Hepatology. 2002. PMID: 12407576 Review.
[Treatment of chronic hepatitis B].
Asselah T, Castelnau C, Boyer N, Ripault MP, Marcellin P. Asselah T, et al. Gastroenterol Clin Biol. 2004 Dec;28(12):1215-27. doi: 10.1016/s0399-8320(04)95213-x. Gastroenterol Clin Biol. 2004. PMID: 15671931 Free article. Review. French. No abstract available.
Treatment of chronic hepatitis c.
Marcellin P, Asselah T, Ripault MP, Boyer N. Marcellin P, et al. Among authors: asselah t. Minerva Gastroenterol Dietol. 2004 Mar;50(1):29-36. Minerva Gastroenterol Dietol. 2004. PMID: 15719004 Review.
[Chronic hepatitis B: which patients should be treated and how?].
Asselah T, Ripault MP, Marcellin P. Asselah T, et al. Gastroenterol Clin Biol. 2005 Apr;29(4):374-83. doi: 10.1016/s0399-8320(05)80784-5. Gastroenterol Clin Biol. 2005. PMID: 15864198 Free article. Review. French. No abstract available.
[Treatment of chronic hepatitis B].
Marcellin P, Asselah T, Boyer N. Marcellin P, et al. Among authors: asselah t. Rev Prat. 2005 Mar 31;55(6):624-32. Rev Prat. 2005. PMID: 15913114 Free article. Review. French.
Treatment of chronic hepatitis B.
Marcellin P, Asselah T, Boyer N. Marcellin P, et al. Among authors: asselah t. J Viral Hepat. 2005 Jul;12(4):333-45. doi: 10.1111/j.1365-2893.2005.00599.x. J Viral Hepat. 2005. PMID: 15985003 Free article. Review.
295 results